Acute Kidney Injury and Kidney Replacement Therapy in the Critically Ill Patient
Acute Kidney Injury
Bairy M. Using kinetic eGFR for drug dosing in AKI:
concordance between kinetic eGFR, Cockcroft-Gault
estimated creatinine clearance, and MDRD eGFR for
drug dosing categories in a pilot study cohort. Nephron.
2020;144(6):299-303. https://doi.org/10.1159/000507260
Barreto EF, Gaggani AM, Hernandez BN, et al. The
(AKIP) list: standardized list of medications that are
renally eliminated and nephrotoxic in the acutely ill.
org/10.1177/10600280241273191
Bellomo R, Ronco C, Kellum JA, et al; Acute Dialysis
Quality Initiative Workgroup. Acute renal failureβ
definition, outcome measures, animal models, fluid
therapy and information technology needs: the Second
International Consensus Conference of the Acute
2004;8(4):R204-R212. https://doi.org/10.1186/cc2872
Bentley ML, Corwin HL, Dasta J. Drug-induced
acute kidney injury in the critically ill adult: rec-
2010;38(6
suppl):S169-S174.
https://doi.org/10.1097/
ccm.0b013e3181de0c60
Campbell RE, Chen CH, Edelstein CL. Overview
of
antibiotic-induced
nephrotoxicity.
Kidney
Int
Rep.
2023;8(11):2211-2225.
https://doi.org/10.1016/j.
ekir.2023.08.031
Chen S. Retooling the creatinine clearance equation
to estimate kinetic GFR when the plasma creatinine is
changing acutely. J Am Soc Nephrol. 2013;24(6):877-
888. https://doi.org/10.1681/asn.2012070653
GΓΆcze I, Jauch D, GΓΆtz M, et al. Biomarker-guided
intervention to prevent acute kidney injury after major
surgery: the prospective randomized BigpAK study. Ann
Surg. 2018;267(6):1013-1020. https://doi.org/10.1097/
sla.0000000000002485
Clin.
2021;37(2):303-320.
https://doi.org/10.1016/j.
ccc.2020.11.002
Karimzadeh I, Barreto EF, Kellum JA, et al. Moving
toward a contemporary classification of drug-induced
org/10.1186/s13054-023-04720-2
Kellum JA, Romagnani P, Ashuntantang G, Ronco
C, Zarbock A, Anders HJ. Acute kidney injury. Nat
Rev Dis Primers. 2021;7(1):52. https://doi.org/10.1038/
s41572-021-00284-z
Kidney Disease: Improving Global Outcomes (KDIGO)
Acute Kidney Injury Work Group. KDIGO clinical prac-
tice guideline for acute kidney injury. Kidney Int Suppl.
2012;2:1-138. https://doi.org/10.1038/kisup.2012.1v
McCullough PA, Bouchard J, Waikar SS, et al.
Implementation of novel biomarkers in the diagnosis,
prognosis, and management of acute kidney injury:
executive summary from the tenth consensus confer-
ence of the Acute Dialysis Quality Initiative (ADQI).
Contrib
Nephrol.
2013;182:5-12.
https://doi.
org/10.1159/000349962
Mehta RL, Awdishu L, Davenport A, et al. Phenotype
standardization for drug-induced kidney disease.
Kidney Int. 2015;88(2):226-234. https://doi.org/10.1038/
ki.2015.115
Miano TA, Hennessy S, Yang W, et al. Association of
vancomycin plus piperacillin-tazobactam with early
changes in creatinine versus cystatin C in critically
Med.
2022;48(9):1144-1155.
https://doi.org/10.1007/
s00134-022-06811-0
Ostermann M, Bellomo R, Burdmann EA, et al.
Controversies in acute kidney injury: conclusions from a
Kidney Disease: Improving Global Outcomes (KDIGO)
conference. Kidney Int. 2020;98(2):294-309. https://doi.
org/10.1016/j.kint.2020.04.020
OβSullivan ED, Doyle A. The clinical utility of kinetic
glomerular filtration rate. Clin Kidney J. 2017;10(2):202-
208. https://doi.org/10.1093/ckj/sfw108
Pais GM, Liu J, Avedissian SN, et al. Lack of synergis-
tic nephrotoxicity between vancomycin and piperacillin/
tazobactam in a rat model and a confirmatory cellular
model. J Antimicrob Chemother. 2020;75(5):1228-1236.
https://doi.org/10.1093/jac/dkz563
Schreier DJ, Kashani KB, Sakhuja A, et al. Incidence
of acute kidney injury among critically ill patients with
brief empiric use of antipseudomonal Ξ²-lactams with
vancomycin. Clin Infect Dis. 2019;68(9):1456-1462.
https://doi.org/10.1093/cid/ciy724